Sponsor Pipeline

DexCom, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT06601166
CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin		 Trial sites expanded: 18 -> 21 locations
Active Trials by Phase
Phase 4
1
Phase 1
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07603284 Continuous Glucose Monitoring By DExcom iN PEople Followed for Type 2 DIabeTes on Insulin… Type 2 Diabetes on Insulin Active, Not Recruiting
Phase 1
NCT07681375 Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes… Type 2 Diabetes Active, Not Recruiting
Not specified
NCT06483945 Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom… Diabetes Recruiting
NCT07681024 Global Long-term Outcomes and Real-World Evaluation of Dexcom Continuous Glucose… Diabetes Not Yet Recruiting
NCT06601166 CONtiNuous glucosE Monitoring (CGM) in People wiTh Type 2 Diabetes Not on Insulin Type 2 Diabetes Active, Not Recruiting
Disease Areas
Diabetes (5) Type 2 Diabetes (3)
Get alerts when DexCom, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free